arrow
A

Armeen Mahvash

the university of texas-md anderson cancer center
H指数:28
被引数:3,407

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Utility of Yttrium-90 Radioembolization for the Treatment of Fibrolamellar Hepatocellular Carcinoma: A Tertiary Cancer Center Experience

90钇放射性栓塞术治疗纤维板层型肝细胞癌的效用:一家三级癌症中心的经验

2026-03-280
OAAI
ASO Visual Abstract: Propensity Score-Matched Analysis of Liver Venous Deprivation and Portal Vein Embolization before Planned Hepatectomy in Patients with Extensive Colorectal Liver Metastases and High-risk Factors for Inadequate Regeneration
2025-01-210
PRE
Propensity Score-Matched Analysis of Liver Venous Deprivation and Portal Vein Embolization Before Planned Hepatectomy in Patients with Extensive Colorectal Liver Metastases and High-Risk Factors for Inadequate Regeneration
2024-12-041
PRE
Direct comparison and reproducibility of two segmentation methods for multicompartment dosimetry: round robin study on radioembolization treatment planning in hepatocellular carcinoma
2023-09-124
OAAI
A novel method for predicting hepatocellular carcinoma response to chemoembolization using an intraprocedural CT hepatic arteriography-based enhancement mapping: a proof-of-concept analysis
2023-01-301
OAAI
A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by 90Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma
2021-09-019
OAAI
Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma

联合PD-L1 (阿特珠单抗) 和VEGF (贝伐单抗) 阻断治疗晚期恶性腹膜间皮瘤的疗效、安全性和生物标志物分析

2021-07-1448
OA